-
September 21: The Week in Cancer News
Patients weigh in on the impact of end-of-treatment bells in cancer centers, and a study suggests that current protocols for BRCA screening may miss testing some patients with mutations.
by Kate Yandell
-
September 14: The Week in Cancer News
An article sparks discussion about precision medicine hype, and a study tallies the rare fatal side effects of immune checkpoint inhibitors.
by Kate Yandell
-
September 7: The Week in Cancer News
A study quantifies gains in breast cancer survival in young women, and a cancer doctor reflects on her experience as a cancer patient.
by Kate Yandell
-
August 31: The Week in Cancer News
A study discusses the harms of breast cancer surgery for women in nursing homes, and an oncologist reflects on the use of military metaphors in writing about John McCain's cancer.
by Kate Yandell
-
August 24: The Week in Cancer News
Researchers investigate how often retailers sell cigarettes to minors, and a trial shows the benefits of immunotherapy for melanoma patients with brain metastases.
by Kate Yandell
-
August 17: The Week in Cancer News
Researchers suggest reclassification of low-risk cancers, and an immunotherapy drug is approved for small cell lung cancer.
by Kate Yandell
-
August 10: The Week in Cancer News
Organizations work to broaden eligibility for cancer clinical trials, and an article explores the limitations of personalized mouse models.
by Kate Yandell
-
August 3: The Week in Cancer News
A study indicates that being diagnosed with cancer as a child could lead to financial problems later, and the Trump administration relaxes restrictions on short-term health insurance policies.
by Kate Yandell
-
July 27: The Week in Cancer News
A study asks whether sunless tanning might encourage riskier tanning behavior, and an article investigates the supercomputer Watson's performance.
by Kate Yandell
-
July 20: The Week in Cancer News
A Chinese movie prompts political discourse about the cost of medication, and a study suggests that dining and sleeping habits may contribute to a person's risk of breast and prostate cancer.
by Brad Jones
Cancer Talk
Treating HER2-ultralow Breast Cancer
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore